BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4215133)

  • 1. [Sulfamethoxazole-trimethoprim: bacteriological experiences after 5 years of use].
    Kayser FH; Santanam P
    Schweiz Med Wochenschr; 1974 Dec; 104(52):1950-4. PubMed ID: 4215133
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of in vitro antibacterial activities of the combination of trimethoprim and sulfamethoxazole on clinical isolates in Japan.
    J Infect Dis; 1973 Nov; 128():Suppl:502-7 p. PubMed ID: 4585955
    [No Abstract]   [Full Text] [Related]  

  • 4. Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.
    Bushby SR
    J Infect Dis; 1973 Nov; 128():Suppl:442-62 p. PubMed ID: 4585951
    [No Abstract]   [Full Text] [Related]  

  • 5. On the sensitivity of pseudomonas and proteus to the combination of trimethoprim and sulphamethoxazole.
    Ritzerfeld W; Hasch B
    Chemotherapy; 1972; 17(5):348-55. PubMed ID: 4205551
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectivity of a sulfonamide-trimethoprim combination against various gram-negative rods and gram-positive cocci in the agar diffusion test].
    Tiesler E
    Med Klin; 1970 Oct; 65(42):1825-8. PubMed ID: 4933237
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activity of biseptol, sulfamethoxazole and trimethoprim against gram positive cocci].
    Grzybowski A; Piatkowski K
    Med Dosw Mikrobiol; 1975; 27(2):101-6. PubMed ID: 806754
    [No Abstract]   [Full Text] [Related]  

  • 9. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.
    Bach MC; Finland M; Gold O; Wilcox C
    J Infect Dis; 1973 Nov; 128():Suppl:508-33 p. PubMed ID: 4148416
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the microbial resistance to the drug combination sulfamethoxazole trimethroprim with special reference to enterococci].
    Gärtner H; Dieterich F
    Arzneimittelforschung; 1973 Apr; 23(4):597-600. PubMed ID: 4197072
    [No Abstract]   [Full Text] [Related]  

  • 12. [The sulfamethoxazole-trimethoprim combination 1st survey into its in vitro activity in brazzaville, Congo Results of 780 bacterial strains isolated at the National Laboratory and the General Hospital in a single year].
    Yala F
    Bull Soc Pathol Exot Filiales; 1979; 72(3):198-204. PubMed ID: 400121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Septrin. Sensitivity of pathogenic bacteria to Septrin].
    Gutkowska J; Zalewski T; Zmudzka B
    Pol Tyg Lek; 1973 Oct; 28(41):1608-10. PubMed ID: 4765468
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synergism of trimethoprim and sulfamethoxazole action on microorganisms isolated from persons with urinary tract infections].
    Ganczarski A; Augustyniak B; Kloczkowski K; Prelich A; Stapor K
    Med Dosw Mikrobiol; 1972; 24(4):307-14. PubMed ID: 4632270
    [No Abstract]   [Full Text] [Related]  

  • 15. In-vitro sensitivity of 368 urinary organisms to trimethoprim-sulphamethoxazole and other antibacterials.
    Hunter IJ
    Med J Aust; 1970 Aug; 2(7):317-21. PubMed ID: 4319442
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sensitivity of bacterial strains to Biseptol. I. Effect of Biseptol, sulfamethoxazole and trimethoprim against Gram-negative bacteria].
    Piatkowski K; Horoszewicz-Malafiej A; Malafiej E
    Med Dosw Mikrobiol; 1974; 26(4):281-9. PubMed ID: 4444372
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sensitivity range of gram-negative microorganisms and mycoplasms to minocycline in vitro].
    Schmid E; Price P; Krech U
    Arzneimittelforschung; 1974 Sep; 24(9):1256-8. PubMed ID: 4373015
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined action of sulphamethoxazole and trimethoprim against clinically-isolated sulphonamide-resistant bacteria.
    Grey D; Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1979; 25(5):296-302. PubMed ID: 383418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reappraisal of the antibacterial action of cotrimoxazole in vitro.
    Lewis EL; Anderson JD; Lacey RW
    J Clin Pathol; 1974 Feb; 27(2):87-91. PubMed ID: 4596417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial activity of the combination trimethoprim-sulfamethoxazole compared with antibiotics].
    Böhni E
    Schweiz Med Wochenschr; 1969 Oct; 99(42):1505-10. PubMed ID: 4903288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.